Clinical Trial Update: Extension Study to Evaluate Safety and Tolerability of Peginesatide for Long-Term Treatment of Anemia in Participants With CKD (EU) [Phase 2]

View source ↗

Summary

Extension study evaluating long-term safety and tolerability of peginesatide for anemia in chronic kidney disease; the trial was terminated with results posted …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia
• Chronic Kidney Disease

Drugs mentioned

• OMontys (peginesatide)

Snippet

Sponsor: Affymax | Conditions: Chronic Renal Failure, Chronic Kidney Disease | Phase 2 | Status: TERMINATED | Results posted: 2012-05-28